Status:
COMPLETED
Contrast-Associated Nephropathy Risk Evaluation in Acute Ischemic Stroke After Endovascular Thrombectomy
Lead Sponsor:
Niguarda Hospital
Conditions:
Contrast-Associated Acute Kidney Injury
Eligibility:
All Genders
18+ years
Brief Summary
The CAN-REST study is a multicenter, observational, and retrospective study aimed at evaluating the incidence and risk factors of contrast-associated acute kidney injury (CA-AKI) in patients with acut...
Detailed Description
The CAN-REST study is a multicenter, observational, and retrospective study designed to evaluate the incidence and risk factors of contrast-associated acute kidney injury (CA-AKI) in patients who have...
Eligibility Criteria
Inclusion
- To be eligible to participate in this study, subjects must meet all of the following criteria:
- Age \>18 years at the time of AIS
- Documented serum creatinine:
- pre-EVT and
- within 48h and/or within 7 days after EVT. Patients on chronic dialysis will be collected but excluded from the analyses
Exclusion
Key Trial Info
Start Date :
March 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2025
Estimated Enrollment :
8000 Patients enrolled
Trial Details
Trial ID
NCT06596603
Start Date
March 1 2023
End Date
July 1 2025
Last Update
July 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ASST Grande Ospedale Metropolitano Niguarda
Milan, Lombardy, Italy, 20162